News Daily News Year in Review: Pulsed-Field Ablation Again Tops Heart Rhythm News Todd Neale December 24, 2025
News Daily News AI Has Great Potential in CV Pharmacotherapy, but Much Work Lies Ahead: Review Todd Neale July 24, 2025
News Daily News Biomarker-Based Risk Score Better Predicts Stroke in AF Than Clinical Tools Todd Neale March 19, 2025
News Conference News ESC 2024 STEEER-AF: Educating Healthcare Workers Improves Adherence to Guidelines Todd Neale September 06, 2024
News Daily News Aligning Pill Burden and Palliative Care Needs in Late-Stage CVD: AHA L.A. McKeown July 02, 2024
News Conference News EACTS 2023 Combined Surgical and Catheter Ablation Best for Persistent AF Michael O'Riordan October 12, 2023
News Daily News Prescribing a Generic for CVD? Plan, Drug Type, and Condition Impact Availability Todd Neale September 13, 2023
News Daily News Borderline Cost-effectiveness for SGLT2 Inhibitors in HFpEF Todd Neale March 15, 2023
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for June 2022 Caitlin E. Cox July 04, 2022
News Daily News Apixaban Appears Safer, More Effective Than Rivaroxaban in Medicare Study Todd Neale December 27, 2021
News Conference News HRS 2021 Catheter Ablation ‘Good Value’ in CABANA Economic Analysis Michael O'Riordan August 04, 2021
News Conference News ESC 2020 Rhythm Control Cuts First CV Events in Early Atrial Fibrillation: EAST-AFNET 4 Shelley Wood August 29, 2020
News Conference News ESC 2019 Increasing Oral Anticoagulation Use Tied to Less Ischemic Stroke in A-fib Patients in Italy Todd Neale August 31, 2019
News Conference News EHRA 2019 Streamlined Procedure Maintains Benefits of Cryoablation Over Drugs for Paroxysmal A-fib Todd Neale March 20, 2019
News Daily News Good INR Control on Warfarin Doesn’t Necessarily Predict Future Success, Outcomes Todd Neale September 13, 2018
News Daily News Rivaroxaban, Warfarin Provide Similar Results Early After Mild Strokes Related to A-fib Todd Neale September 14, 2017
News Daily News Apixaban Provides ‘Intermediate-Value’ Care, New Economic Analysis Shows Michael O'Riordan March 31, 2017
News Daily News Drug Company Payments to Physicians May Be Influencing Prescribing Todd Neale August 23, 2016
News Daily News ARISTOTLE Analysis: Don’t Shy Away From Standard Apixaban Dose in Certain High-Risk Patients Todd Neale July 29, 2016
News Daily News No Money, No Drugs: Global Barriers to Secondary CVD Prevention Caitlin E. Cox October 27, 2015